Biogen Inc (BIIB)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BIIB? Forum Prognose Aktiensplit

Finanzdaten der Biogen Inc-Aktie (BIIB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.82% 2,645.50	2,431.00	2,465.80	2,464.90	2,290.50
Cost Of Revenue	3.86% 605.00	629.30	638.70	546.00	542.20
Gross Profit	13.25% 2,040.50	1,801.70	1,827.10	1,918.90	1,748.30
Operating Expenses	13.02% 1,296.50	1,490.50	1,376.10	1,220.20	1,283.50
Interest Income/Expense	21.00% 72.60	60.00	59.80	61.30	69.20
Benefits Costs and Expenses	10.30% 1,901.50	2,119.80	2,014.80	1,766.20	1,825.70
Costs And Expenses	10.30% 1,901.50	2,119.80	2,014.80	1,766.20	1,825.70
Operating Income/Loss	139.07% 744.00	311.20	451.00	698.70	464.80
Income/Loss From Continuing Operations Before Tax	139.07% 744.00	311.20	451.00	698.70	464.80
Income Tax Expense/Benefit, Deferred	12.59% -31.30	-27.80	-52.60	-87.00	39.90
Income Tax Expense/Benefit	54.46% 109.20	70.70	62.50	115.10	71.40
Income/Loss From Continuing Operations After Tax	163.95% 634.80	240.50	388.50	583.60	393.40
Net Income/Loss	163.95% 634.80	240.50	388.50	583.60	393.40
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.27% 146.50	146.10	145.70	145.60	145.20
Diluted Average Shares	0.07% 146.70	146.60	146.10	145.90	145.90
Basic Earnings Per Share	162.42% 4.33	1.65	2.67	4.01	2.71
Diluted Earnings Per Share	164.02% 4.33	1.64	2.66	4.00	2.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SNY

$50.05

1.05%

PFE

$24.66

0.04%

GILD

$122.05

1.89%

AMGN

$296.30

0.71%

NVO

$49.11

0.71%

MRK

$82.49

4.06%